Who is sponsoring NCT04810143?

NCT04810143 is sponsored by Children's Hospital Medical Center, Cincinnati.

What drugs are being tested in NCT04810143?

Interventions in NCT04810143: Mitra Microsampler.

What condition does NCT04810143 study?

NCT04810143 studies Validate Volumetric Absorptive Microsampling (VAMS) Assay.

Is NCT04810143 still recruiting?

NCT04810143 is currently completed. Last updated 20 December 2022.

Last reviewed 2022-12-20 · How we verify

NCT04810143: VAMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tacrolimus Microsampling

Completed NA Last updated 20 December 2022

What this trial tests

NA trial testing Mitra Microsampler in Validate Volumetric Absorptive Microsampling (VAMS) Assay in 16 participants. Completed in 28 July 2022.

Timeline

7 October 2019

Primary endpoint
3 January 2022

28 July 2022

Quick facts

Lead sponsor	Children's Hospital Medical Center, Cincinnati
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	16
Start date	7 October 2019
Primary completion	3 January 2022
Estimated completion	28 July 2022
Sites	1 location across United States

Drugs / interventions tested

Mitra Microsampler

Conditions studied

Validate Volumetric Absorptive Microsampling (VAMS) Assay — all drugs for Validate Volumetric Absorptive Microsampling (VAMS) Assay →

Sponsor

Children's Hospital Medical Center, Cincinnati

Who can join

Adults 1 to 21, any sex, with Validate Volumetric Absorptive Microsampling (VAMS) Assay. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a feasibility study at a single site, Cincinnati Children's Hospital Medical Center. Patients who have undergone heart transplantation who meet eligibility requirements will be approached to participate in the study. The purpose of this study is to establish a reliable, home-based method for collecting samples as well as a standardized method for use of small-volume samples on both inpatients and outpatients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Children's Hospital Medical Center, Cincinnati trials

Trials by the same sponsor.

NCT07430332 — GLP-1 RA for Stage 1 Type 1 Diabetes · Phase 2 · not yet recruiting
NCT07077213 — 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients · recruiting
NCT07265141 — An Automated Virtual Reality Intervention to Enhance Firearm Safety Counseling in Pediatrics · NA · not yet recruiting
NCT07217444 — Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation · NA · recruiting
NCT07195123 — Evaluation of the SMART IBD App in Pediatric IBD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04810143 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati
Last refreshed: 20 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04810143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing